JP2017505791A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017505791A5 JP2017505791A5 JP2016551224A JP2016551224A JP2017505791A5 JP 2017505791 A5 JP2017505791 A5 JP 2017505791A5 JP 2016551224 A JP2016551224 A JP 2016551224A JP 2016551224 A JP2016551224 A JP 2016551224A JP 2017505791 A5 JP2017505791 A5 JP 2017505791A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- acid
- antiperspirant
- antiperspirant composition
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims description 154
- 230000001166 anti-perspirative effect Effects 0.000 claims description 102
- 239000003213 antiperspirant Substances 0.000 claims description 102
- 238000000034 method Methods 0.000 claims description 61
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 claims description 38
- 239000002253 acid Substances 0.000 claims description 34
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 208000008454 Hyperhidrosis Diseases 0.000 claims description 18
- 239000002537 cosmetic Substances 0.000 claims description 18
- 239000007954 growth retardant Substances 0.000 claims description 18
- 229920005862 polyol Polymers 0.000 claims description 17
- 150000003077 polyols Chemical class 0.000 claims description 17
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 12
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 12
- 239000002202 Polyethylene glycol Substances 0.000 claims description 12
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 12
- 150000001732 carboxylic acid derivatives Chemical group 0.000 claims description 12
- 150000001768 cations Chemical class 0.000 claims description 12
- 239000002245 particle Substances 0.000 claims description 12
- 229920001223 polyethylene glycol Polymers 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 11
- 239000004480 active ingredient Substances 0.000 claims description 10
- 239000003125 aqueous solvent Substances 0.000 claims description 10
- 229920001515 polyalkylene glycol Polymers 0.000 claims description 10
- 230000035900 sweating Effects 0.000 claims description 10
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 claims description 8
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 8
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 claims description 8
- 235000001014 amino acid Nutrition 0.000 claims description 8
- 150000001413 amino acids Chemical class 0.000 claims description 8
- 150000001720 carbohydrates Chemical class 0.000 claims description 8
- 230000037315 hyperhidrosis Effects 0.000 claims description 8
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 8
- WLJVNTCWHIRURA-UHFFFAOYSA-N pimelic acid Chemical compound OC(=O)CCCCCC(O)=O WLJVNTCWHIRURA-UHFFFAOYSA-N 0.000 claims description 8
- 125000001453 quaternary ammonium group Chemical group 0.000 claims description 8
- 238000009472 formulation Methods 0.000 claims description 7
- 229920002307 Dextran Polymers 0.000 claims description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- 238000003556 assay Methods 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 6
- 208000035985 Body Odor Diseases 0.000 claims description 5
- 206010040904 Skin odour abnormal Diseases 0.000 claims description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 claims description 4
- 239000004215 Carbon black (E152) Substances 0.000 claims description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 4
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 claims description 4
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 4
- UNXHWFMMPAWVPI-QWWZWVQMSA-N D-threitol Chemical compound OC[C@@H](O)[C@H](O)CO UNXHWFMMPAWVPI-QWWZWVQMSA-N 0.000 claims description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 4
- 239000004386 Erythritol Substances 0.000 claims description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 4
- 229930091371 Fructose Natural products 0.000 claims description 4
- 239000005715 Fructose Substances 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 206010020850 Hyperthyroidism Diseases 0.000 claims description 4
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 4
- 229930195725 Mannitol Natural products 0.000 claims description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 4
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 4
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 4
- 239000001361 adipic acid Substances 0.000 claims description 4
- 235000011037 adipic acid Nutrition 0.000 claims description 4
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 claims description 4
- 150000001449 anionic compounds Chemical class 0.000 claims description 4
- 235000003704 aspartic acid Nutrition 0.000 claims description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 4
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 4
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims description 4
- 239000003974 emollient agent Substances 0.000 claims description 4
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 4
- 235000019414 erythritol Nutrition 0.000 claims description 4
- 229940009714 erythritol Drugs 0.000 claims description 4
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 claims description 4
- 239000000174 gluconic acid Substances 0.000 claims description 4
- 235000012208 gluconic acid Nutrition 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 229930195733 hydrocarbon Natural products 0.000 claims description 4
- 150000002430 hydrocarbons Chemical class 0.000 claims description 4
- 238000000338 in vitro Methods 0.000 claims description 4
- 239000003112 inhibitor Substances 0.000 claims description 4
- 229910001412 inorganic anion Inorganic materials 0.000 claims description 4
- 239000007791 liquid phase Substances 0.000 claims description 4
- 239000000594 mannitol Substances 0.000 claims description 4
- 235000010355 mannitol Nutrition 0.000 claims description 4
- 235000006408 oxalic acid Nutrition 0.000 claims description 4
- 239000012071 phase Substances 0.000 claims description 4
- 229920001451 polypropylene glycol Polymers 0.000 claims description 4
- 229920001296 polysiloxane Polymers 0.000 claims description 4
- 239000011148 porous material Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- HEBKCHPVOIAQTA-ZXFHETKHSA-N ribitol Chemical compound OC[C@H](O)[C@H](O)[C@H](O)CO HEBKCHPVOIAQTA-ZXFHETKHSA-N 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- 239000000600 sorbitol Substances 0.000 claims description 4
- 235000002906 tartaric acid Nutrition 0.000 claims description 4
- 239000011975 tartaric acid Substances 0.000 claims description 4
- 239000000811 xylitol Substances 0.000 claims description 4
- 235000010447 xylitol Nutrition 0.000 claims description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 4
- 229960002675 xylitol Drugs 0.000 claims description 4
- -1 Ca 2+ Chemical class 0.000 claims description 3
- 230000009089 cytolysis Effects 0.000 claims description 3
- 239000003205 fragrance Substances 0.000 claims description 3
- 239000000375 suspending agent Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 2
- 208000030507 AIDS Diseases 0.000 claims description 2
- 206010000599 Acromegaly Diseases 0.000 claims description 2
- 208000019901 Anxiety disease Diseases 0.000 claims description 2
- 206010007270 Carcinoid syndrome Diseases 0.000 claims description 2
- 239000007995 HEPES buffer Substances 0.000 claims description 2
- 208000019693 Lung disease Diseases 0.000 claims description 2
- 206010028980 Neoplasm Diseases 0.000 claims description 2
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims description 2
- 208000008589 Obesity Diseases 0.000 claims description 2
- 208000018737 Parkinson disease Diseases 0.000 claims description 2
- 206010037660 Pyrexia Diseases 0.000 claims description 2
- 208000006011 Stroke Diseases 0.000 claims description 2
- 229940123445 Tricyclic antidepressant Drugs 0.000 claims description 2
- 239000000443 aerosol Substances 0.000 claims description 2
- 125000003158 alcohol group Chemical group 0.000 claims description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 2
- 229910052782 aluminium Inorganic materials 0.000 claims description 2
- 230000036506 anxiety Effects 0.000 claims description 2
- 239000002876 beta blocker Substances 0.000 claims description 2
- 229940097320 beta blocking agent Drugs 0.000 claims description 2
- 201000011510 cancer Diseases 0.000 claims description 2
- 206010012601 diabetes mellitus Diseases 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 206010014665 endocarditis Diseases 0.000 claims description 2
- 208000019622 heart disease Diseases 0.000 claims description 2
- 208000015181 infectious disease Diseases 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims description 2
- 208000032839 leukemia Diseases 0.000 claims description 2
- 238000002483 medication Methods 0.000 claims description 2
- 230000009245 menopause Effects 0.000 claims description 2
- MEFBJEMVZONFCJ-UHFFFAOYSA-N molybdate Chemical compound [O-][Mo]([O-])(=O)=O MEFBJEMVZONFCJ-UHFFFAOYSA-N 0.000 claims description 2
- 208000010125 myocardial infarction Diseases 0.000 claims description 2
- 239000000346 nonvolatile oil Substances 0.000 claims description 2
- 235000020824 obesity Nutrition 0.000 claims description 2
- 208000028591 pheochromocytoma Diseases 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 208000020431 spinal cord injury Diseases 0.000 claims description 2
- 201000009032 substance abuse Diseases 0.000 claims description 2
- 231100000736 substance abuse Toxicity 0.000 claims description 2
- 208000011117 substance-related disease Diseases 0.000 claims description 2
- 239000003029 tricyclic antidepressant agent Substances 0.000 claims description 2
- 201000008827 tuberculosis Diseases 0.000 claims description 2
- 239000000341 volatile oil Substances 0.000 claims description 2
- 150000003754 zirconium Chemical class 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims 5
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- 239000000084 colloidal system Substances 0.000 claims 1
- 239000000178 monomer Substances 0.000 claims 1
- 239000002304 perfume Substances 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 210000004243 sweat Anatomy 0.000 claims 1
- 229960001231 choline Drugs 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000061 acid fraction Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Images
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201402669A GB201402669D0 (en) | 2014-02-14 | 2014-02-14 | Stabilised silicate compositions and their uses |
| GB1402669.4 | 2014-02-14 | ||
| PCT/GB2015/050410 WO2015121667A1 (en) | 2014-02-14 | 2015-02-13 | Stabilised silicate compositions and their use as antiperspirant compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017505791A JP2017505791A (ja) | 2017-02-23 |
| JP2017505791A5 true JP2017505791A5 (enExample) | 2018-03-29 |
| JP6814635B2 JP6814635B2 (ja) | 2021-01-20 |
Family
ID=50440201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016551224A Expired - Fee Related JP6814635B2 (ja) | 2014-02-14 | 2015-02-13 | 安定化されたケイ酸塩組成物及び制汗剤組成物としてのその使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20170007531A1 (enExample) |
| EP (1) | EP3104829B1 (enExample) |
| JP (1) | JP6814635B2 (enExample) |
| KR (1) | KR102309504B1 (enExample) |
| CN (1) | CN106102694B (enExample) |
| AU (1) | AU2015216712B2 (enExample) |
| BR (1) | BR112016018654B1 (enExample) |
| CA (1) | CA2939050A1 (enExample) |
| EA (1) | EA036306B1 (enExample) |
| ES (1) | ES2815571T3 (enExample) |
| GB (1) | GB201402669D0 (enExample) |
| MX (1) | MX379358B (enExample) |
| WO (1) | WO2015121667A1 (enExample) |
| ZA (1) | ZA201605438B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201402672D0 (en) * | 2014-02-14 | 2014-04-02 | Medical Res Council | Materials and methods relating to stabilised polymeric silicate compositions |
| DE102015214144A1 (de) * | 2015-07-27 | 2017-02-02 | Beiersdorf Ag | Schweiß verringernde kosmetische Zubereitung |
| DE102015214146A1 (de) * | 2015-07-27 | 2017-02-02 | Beiersdorf Ag | Schweiß verringernde kosmetische Zubereitung |
| DE102015214143A1 (de) * | 2015-07-27 | 2017-02-02 | Beiersdorf Ag | Schweiß verringernde kosmetische Zubereitung |
| DE102015214145A1 (de) * | 2015-07-27 | 2017-02-02 | Beiersdorf Ag | Schweiß verringernde kosmetische Zubereitung |
| DE102015214140A1 (de) * | 2015-07-27 | 2017-02-02 | Beiersdorf Ag | Schweiß verringernde kosmetische Zubereitung |
| DE102015214137A1 (de) * | 2015-07-27 | 2017-02-02 | Beiersdorf Ag | Schweiß verringernde kosmetische Zubereitung |
| DE102015226630A1 (de) * | 2015-12-23 | 2017-06-29 | Beiersdorf Ag | Verfahren zur Schweißreduktion |
| FR3061430B1 (fr) * | 2016-12-30 | 2019-05-24 | L'oreal | Procede cosmetique pour prevenir et/ou traiter la transpiration et eventuellement les odeurs corporelles. |
| DE102018207702A1 (de) * | 2018-05-17 | 2019-11-21 | Beiersdorf Ag | Verfahren zur Schweißreduktion mit Malonsäure |
| FR3083092A1 (fr) | 2018-06-29 | 2020-01-03 | L'oreal | Composition cosmetique comprenant une dispersion colloidale de particules de silice |
| EP3714879A1 (en) | 2019-03-28 | 2020-09-30 | Sisaf Ltd | Structured encapsulated silicon-containing particles |
| GB201904337D0 (en) | 2019-03-28 | 2019-05-15 | Sisaf Ltd | A delivery system |
| GB201904334D0 (en) | 2019-03-28 | 2019-05-15 | Sisaf Ltd | Carrier system for preparing herbaceous extracts |
| GB201904336D0 (en) | 2019-03-28 | 2019-05-15 | Sisaf Ltd | A delivery system |
| KR102207608B1 (ko) * | 2019-04-24 | 2021-01-26 | 윤종오 | 카르복실산으로 유기화된 규소 이온 복합체 및 복합체의 제조방법과 이를 이용한 제품 |
| WO2020218834A1 (ko) * | 2019-04-24 | 2020-10-29 | 윤종오 | 카르복실산으로 유기화된 규소 이온 복합체 및 복합체의 제조방법과 이를 이용한 제품 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT302146B (de) * | 1968-06-12 | 1972-10-10 | Du Pont | Kieselsäure enthaltende Masse, insbesondere zur Herstellung von Kieselsäuregel und geformten Erzeugnissen |
| US3932609A (en) * | 1974-03-29 | 1976-01-13 | Estee Lauder Inc. | Antiperspirant composition |
| CA1330538C (en) * | 1988-04-14 | 1994-07-05 | Maria A. Curtin | Antiperspirant and method of making same |
| US5330751A (en) * | 1988-04-14 | 1994-07-19 | The Gilette Company | Antiperspirant and method of making same |
| US5227089A (en) * | 1990-10-01 | 1993-07-13 | Suido Kiko Kabushiki Kaisha | Method for producing flocculant for water treatment |
| EP0545556B1 (en) | 1991-11-08 | 1997-07-23 | Quest International B.V. | Perfume composition |
| JP2588109B2 (ja) * | 1993-03-19 | 1997-03-05 | 日本臓器製薬株式会社 | 鎮痛剤 |
| NL9400189A (nl) * | 1994-02-07 | 1995-09-01 | Bio Pharma Sciences Bv | Gestabiliseerd orthosiliciumzuur bevattend preparaat, een werkwijze voor het bereiden daarvan en een biologisch preparaat. |
| US5468473A (en) | 1994-02-09 | 1995-11-21 | Innova Products, Inc. | Antiperspirant for hands and feet |
| US6045823A (en) * | 1996-09-19 | 2000-04-04 | Dragoco Gerberding & Co. Ag | Process for producing solid anhydrous composition, and pharmaceutical and cosmetic products comprising same |
| CN1152822C (zh) * | 1997-06-04 | 2004-06-09 | 纳幕尔杜邦公司 | 改进的制备低浓度聚硅铝酸盐微凝胶的方法 |
| CN1312080A (zh) * | 2000-02-18 | 2001-09-12 | 日本脏器制药株式会社 | 含有脂肪酸的组合物 |
| WO2003027015A1 (de) * | 2001-09-21 | 2003-04-03 | Merck Patent Gmbh | Neuartiges hybrid-sol zur herstellung abriebfester sio2-antireflexschichten |
| US7879350B2 (en) * | 2003-10-16 | 2011-02-01 | Kimberly-Clark Worldwide, Inc. | Method for reducing odor using colloidal nanoparticles |
| JP2006176473A (ja) * | 2004-12-24 | 2006-07-06 | Lion Corp | 制汗剤組成物 |
| US7303767B2 (en) * | 2005-02-03 | 2007-12-04 | J.M. Huber Corporation | Personal care compositions comprising coated/treated metal silicate absorbent particles |
| WO2007046102A2 (en) * | 2005-10-19 | 2007-04-26 | Menni Menashe Zinger | Methods for the treatment of hyperhidrosis |
| US20070148113A1 (en) | 2005-12-05 | 2007-06-28 | Cyril Lemoine | Antiperspirant compositions comprising at least one dispersion of cationic colloidal silica particles, antiperspirant product, and cosmetic process for treating perspiration |
| JP2010235431A (ja) * | 2008-05-27 | 2010-10-21 | Central Glass Co Ltd | 薄片状物質及び製法 |
| EP2151466A1 (en) * | 2008-08-01 | 2010-02-10 | SiNatur GmbH | Biologically active silicic acid |
| JP5939730B2 (ja) * | 2008-12-16 | 2016-06-22 | 日本製紙クレシア株式会社 | 含アルコールウエットティシュ |
| WO2012103036A1 (en) * | 2011-01-24 | 2012-08-02 | Anterios, Inc. | Compositions of empty nanoparticles and their use for treating dermatological conditions |
| JP5867192B2 (ja) * | 2012-03-13 | 2016-02-24 | 信越化学工業株式会社 | コーティング用組成物及びプラスチックレンズ |
| AU2013359040A1 (en) | 2012-12-14 | 2015-07-02 | The Procter & Gamble Company | Fragrance materials |
-
2014
- 2014-02-14 GB GB201402669A patent/GB201402669D0/en not_active Ceased
-
2015
- 2015-02-13 MX MX2016010263A patent/MX379358B/es unknown
- 2015-02-13 EA EA201691363A patent/EA036306B1/ru unknown
- 2015-02-13 US US15/117,784 patent/US20170007531A1/en not_active Abandoned
- 2015-02-13 WO PCT/GB2015/050410 patent/WO2015121667A1/en not_active Ceased
- 2015-02-13 AU AU2015216712A patent/AU2015216712B2/en not_active Ceased
- 2015-02-13 CN CN201580008559.1A patent/CN106102694B/zh not_active Expired - Fee Related
- 2015-02-13 CA CA2939050A patent/CA2939050A1/en not_active Abandoned
- 2015-02-13 EP EP15707170.5A patent/EP3104829B1/en not_active Not-in-force
- 2015-02-13 BR BR112016018654-0A patent/BR112016018654B1/pt not_active IP Right Cessation
- 2015-02-13 KR KR1020167021929A patent/KR102309504B1/ko not_active Expired - Fee Related
- 2015-02-13 ES ES15707170T patent/ES2815571T3/es active Active
- 2015-02-13 JP JP2016551224A patent/JP6814635B2/ja not_active Expired - Fee Related
-
2016
- 2016-08-05 ZA ZA2016/05438A patent/ZA201605438B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017505791A5 (enExample) | ||
| JP6814635B2 (ja) | 安定化されたケイ酸塩組成物及び制汗剤組成物としてのその使用 | |
| RU2683779C2 (ru) | Композиции и способы повышения эффективности местного нанесения кислотного полезного агента | |
| RU2722783C2 (ru) | Композиции и способы повышения эффективности местного нанесения щелочного полезного агента | |
| JP5968558B2 (ja) | 亜鉛リジン錯体 | |
| RU2640184C2 (ru) | Безводные порошкообразные и жидкие частицы | |
| KR101850911B1 (ko) | 항균 물질을 갖는 다공성 입자, 그의 제조 방법 및 그를 포함하는 치과용 인상재 | |
| TW201720419A (zh) | 口腔用組合物 | |
| DE102013225620A1 (de) | Schweißhemmende kosmetische Mittel ohne aluminiumhaltige Verbindungen II | |
| JP6152117B2 (ja) | 無水制汗剤組成物 | |
| JP2019501174A (ja) | 制汗法 | |
| DE102013225617A1 (de) | Schweißhemmende kosmetische Mittel ohne aluminiumhaltige Verbindungen I | |
| KR20180076180A (ko) | 워터 드롭 실리콘중수 유화형 화장료 조성물 | |
| KR20200059007A (ko) | 화산석 송이를 함유하는 에멀젼 비드의 제조방법 | |
| WO2015055195A1 (de) | SCHWEIßHEMMENDE KOSMETISCHE MITTEL MIT AMIDOSULFONSÄUREN | |
| EP3057568B1 (de) | Verwendung von methansulfonsäure und ihrer salze zur aktivierung und/oder stabilisierung schweisshemmender aluminiumsalze | |
| CN110072508B (zh) | 无铝止汗剂/除臭剂组合物 | |
| JP6715799B2 (ja) | 口腔用組成物 | |
| JP2011051923A (ja) | ２層型化粧料 | |
| EP3057565A2 (de) | Schweisshemmende kosmetische mittel mit polycarbonsäuren | |
| DE102013220789A1 (de) | Schweißhemmende kosmetische Mittel mit aromatischen Sulfonsäuren | |
| US20160206529A1 (en) | Antiperspirant cosmetic agents having alpha-hydroxy acids | |
| JP6339504B2 (ja) | 新規組成物 | |
| HK1232156B (en) | Stabilised silicate compositions and their use as antiperspirant compositions | |
| KR20140056979A (ko) | 서방형 엘-멘톨 실리카 겔, 이의 제조 방법 및 이를 포함하는 향장 조성물 |